AlgenScribe
Nice
About AlgenScribe
Algenscribe operates in the biotechnology industry, focusing on developing innovative genome editing tools. The company is working on a genome-editing platform aimed at gene and cell therapy, as well as bioproduction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $541.2K
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: algenscribe.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/algenscribe-25185 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.